Lexeo Therapeutics files 8-K reporting asset acquisition
Lexeo Therapeutics filed an 8-K reporting the completion of an asset acquisition and unregistered sales of equity securities.
Lexeo Therapeutics filed an 8-K reporting the completion of an asset acquisition and unregistered sales of equity securities.